Estimating tau onset age from tau PET imaging in two longitudinal cohorts using sampled iterative local approximation
Understanding the time course of Alzheimer's disease biomarkers of amyloid and tau pathology and their temporal relation to clinical symptoms is key to identifying optimal windows for disease intervention and planning future drug trials. The goal of this work was to determine the extent to which Sampled Iterative Local Approximation (SILA), an algorithm extensively validated for amyloid PET, is capable of modeling longitudinal tau (T) PET trajectories and estimating person-level tau positivity onset ages in two commonly analyzed brain regions and two tracers from two different cohorts. Methods: carriers and non-carriers, as well as differences in time T+ between levels of cognitive impairment. Results: carriers (p <0.05) and those with dementia (p <0.05). Conclusions: Our results suggest SILA can be used to accurately model longitudinal tau PET trajectories and retrospectively estimate individual T+ onset ages in the meta-temporal region. The accuracy of SILA time estimates in entorhinal cortex worsened amongst those with dementia in ADNI suggesting entorhinal cortex may only be suitable for studying the temporal progression of tau during the preclinical time frame.
Authors
- Margo B. Heston (ORCID: https://orcid.org/0000-0002-0980-2275)
- Tobey J. Betthauser (ORCID: https://orcid.org/0000-0001-8856-1352)
- William Coath (ORCID: https://orcid.org/0000-0002-3976-9461)
- Hailey Bruzzone
- Jordan P Teague
Institutions
- University of Wisconsin–Madison (US)
- Stanford University (US)
Publication Details
- Journal
- medRxiv
- Published
- 2026-04-03
- DOI
- https://doi.org/10.64898/2026.04.01.26349872
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- Alzheimer's Association
- Bristol-Myers Squibb
- Eli Lilly and Company
- Biogen
- Alzheimer's Disease Neuroimaging Initiative
- BioClinica
- Eisai
- H. Lundbeck A/S
- IXICO
- National Institutes of Health
- Genentech
- National Institute on Aging